DSpace Repository

PATHOPHYSIOLOGICAL SUBSTANTIATION OF THE USE OF A NEW DRUG BASED ON G. LUCIDUM AND ALKHADIA IN THE TREATMENT OF CORONAVIRUS INFECTION CAUSED BY SARS COV-2.

Show simple item record

dc.contributor.author Boboyeva Zuhra Nurullayevna
dc.date.accessioned 2022-12-14T19:28:59Z
dc.date.available 2022-12-14T19:28:59Z
dc.date.issued 2022
dc.identifier.issn 2181-1326
dc.identifier.uri http://repository.tma.uz/xmlui/handle/1/5257
dc.description.abstract The current outbreak of coronavirus disease (COVID-19) is a global emergency as its rapid spread and high mortality rate have caused severe disruption. The number of people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is rapidly increasing worldwide. Patients with COVID-19 may develop pneumonia, severe symptoms of acute respiratory distress syndrome (ARDS) and multiple organ failure en_US
dc.language.iso other en_US
dc.publisher Uzbekistan,Tashkent en_US
dc.subject coronavirus infection, pathogenesis, acute respiratory syndrome, G. lucidum, Alkhadaya. en_US
dc.title PATHOPHYSIOLOGICAL SUBSTANTIATION OF THE USE OF A NEW DRUG BASED ON G. LUCIDUM AND ALKHADIA IN THE TREATMENT OF CORONAVIRUS INFECTION CAUSED BY SARS COV-2. en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account